BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38272563)

  • 1. Multimodal profiling of chordoma immunity reveals distinct immune contextures.
    van Oost S; Meijer DM; Ijsselsteijn ME; Roelands JP; van den Akker BEMW; van der Breggen R; Briaire-de Bruijn IH; van der Ploeg M; Wijers-Koster PM; Polak SB; Peul WC; van der Wal RJP; de Miranda NFCC; Bovee JVMG
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38272563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
    Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
    Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
    Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment.
    Baluszek S; Kober P; Rusetska N; Wągrodzki M; Mandat T; Kunicki J; Bujko M
    Acta Neuropathol Commun; 2023 Jul; 11(1):113. PubMed ID: 37434245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomas.
    Duan W; Zhang B; Li X; Chen W; Jia S; Xin Z; Jian Q; Jian F; Chou D; Chen Z
    Cancer Immunol Immunother; 2022 Sep; 71(9):2185-2195. PubMed ID: 35084549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
    Schwab JH; Boland PJ; Agaram NP; Socci ND; Guo T; O'Toole GC; Wang X; Ostroumov E; Hunter CJ; Block JA; Doty S; Ferrone S; Healey JH; Antonescu CR
    Cancer Immunol Immunother; 2009 Mar; 58(3):339-49. PubMed ID: 18641983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications.
    Jin MC; Connolly ID; Ravi K; Tobert DG; MacDonald SM; Shin JH
    Neurosurg Focus; 2024 May; 56(5):E18. PubMed ID: 38691860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
    Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies.
    Lopez DC; Robbins YL; Kowalczyk JT; Lassoued W; Gulley JL; Miettinen MM; Gallia GL; Allen CT; Hodge JW; London NR
    Front Oncol; 2022; 12():1012058. PubMed ID: 36338744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
    Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
    J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T gene isoform expression pattern is significantly different between chordomas and notochords.
    Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
    Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
    Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
    Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
    Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
    J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.
    Mathios D; Ruzevick J; Jackson CM; Xu H; Shah SR; Taube JM; Burger PC; McCarthy EF; Quinones-Hinojosa A; Pardoll DM; Lim M
    J Neurooncol; 2015 Jan; 121(2):251-9. PubMed ID: 25349132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas.
    Alholle A; Brini AT; Bauer J; Gharanei S; Niada S; Slater A; Gentle D; Maher ER; Jeys L; Grimer R; Sumathi VP; Latif F
    Epigenetics; 2015; 10(3):213-20. PubMed ID: 25621392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular features and vulnerabilities of recurrent chordomas.
    Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
    J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chordoma: the nonsarcoma primary bone tumor.
    Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
    Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors.
    Yoon JY; Jiang W; Orr CR; Rushton C; Gargano S; Song SJ; Modi M; Hozack B; Abraham J; Mallick AB; Brooks JSJ; Rosenbaum JN; Zhang PJ
    Cancer Genet; 2021 Nov; 258-259():74-79. PubMed ID: 34583232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.